Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure | Zendy

Enrico Fiaccadori | Zendy; Umberto Maggiore | Zendy; Elisabetta Parenti | Zendy; Roberto Giacosa | Zendy; Edoardo Picetti | Zendy; Carlo Rotelli | Zendy; Dante Tagliavini | Zendy; Aderville Cabassi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure

Author(s) -

Enrico Fiaccadori,

Umberto Maggiore,

Elisabetta Parenti,

Roberto Giacosa,

Edoardo Picetti,

Carlo Rotelli,

Dante Tagliavini,

Aderville Cabassi

Publication year - 2006

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl627

Subject(s) - medicine , dialysis , acute kidney injury , hemodialysis , hemofiltration , renal replacement therapy , anesthesia , prostacyclin , sepsis , intensive care unit , surgery

Prostacyclin is an easy-to-use and safe antihaemostatic drug for continuous renal replacement therapies (RRTs). No study has been performed so far about its use in critically ill patients with acute renal failure (ARF) treated with sustained low-efficiency dialysis (SLED), a hybrid modality between conventional intermittent and continuous RRTs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research